Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High?

Core Viewpoint - ARS Pharmaceuticals, Inc. (SPRY) shows significant upside potential with a mean price target of $32, indicating a 78.8% increase from the current price of $17.9 [1] Price Targets - The average price target from analysts ranges from a low of $28.00 to a high of $40.00, with a standard deviation of $4.69, suggesting a consensus among analysts [2] - The lowest estimate indicates a potential increase of 56.4%, while the highest estimate suggests a 123.5% upside [2] Analyst Sentiment - Analysts have shown increasing optimism regarding SPRY's earnings prospects, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 3.1%, with one estimate moving higher and no negative revisions [12] Zacks Rank - SPRY currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the exact price gain, it does provide a good guide for the direction of price movement [14]